Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon?
Bugatti
Leonardo
L
Filosa
Giorgio
G
Nicolini
Massimiliano
M
Filosa
Alessandra
A
Verdolini
Roberto
R
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D017445:Skin Diseases, Vascular / Q000139:chemically induced*
D000970:Antineoplastic Agents; D016898:Interferon-alpha